☰

Christopher Leland Herold - Publications

Affiliations: 
2002 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L, Steplewski K, Aiyar N, Douglas SA. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn-Schmiedeberg's Archives of Pharmacology. 370: 238-50. PMID 15549273 DOI: 10.1007/s00210-004-0980-z  0.329
2004 Douglas SA, Naselsky D, Ao Z, Disa J, Herold CL, Lynch F, Aiyar NV. Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. British Journal of Pharmacology. 142: 921-32. PMID 15210573 DOI: 10.1038/sj.bjp.0705743  0.452
2004 Behm DJ, Herold CL, Camarda V, Aiyar NV, Douglas SA. Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors. European Journal of Pharmacology. 492: 113-6. PMID 15178353 DOI: 10.1016/j.ejphar.2004.03.059  0.6
2004 Herold CL, Qi AD, Harden TK, Nicholas RA. Agonist versus antagonist action of ATP at the P2Y4 receptor is determined by the second extracellular loop. The Journal of Biological Chemistry. 279: 11456-64. PMID 14670966 DOI: 10.1074/Jbc.M301734200  0.594
2003 Herold CL, Behm DJ, Buckley PT, Foley JJ, Wixted WE, Sarau HM, Douglas SA. The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors. British Journal of Pharmacology. 139: 203-7. PMID 12770925 DOI: 10.1038/sj.bjp.0705251  0.701
2002 Behm DJ, Herold CL, Ohlstein EH, Knight SD, Dhanak D, Douglas SA. Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist. British Journal of Pharmacology. 137: 449-58. PMID 12359626 DOI: 10.1038/sj.bjp.0704887  0.437
2000 Kennedy C, Qi AD, Herold CL, Harden TK, Nicholas RA. ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. Molecular Pharmacology. 57: 926-31. PMID 10779375  0.624
1997 Herold CL, Li Q, Schachter JB, Harden TK, Nicholas RA. Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7. Biochemical and Biophysical Research Communications. 235: 717-21. PMID 9207227 DOI: 10.1006/Bbrc.1997.6884  0.577
Show low-probability matches.